Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring Predictors of Symptoms Relapse After Discontinuation of Successful Treatment With a Tolterodine Prolonged Release Capsules (4 mg, Once Daily) in Overactive Bladder Patients: A Prospective Randomized Multicenter Trial

NCT00730535 is registered in ClinicalTrials.gov with KYU-SUNG LEE as lead sponsor.

NCT NCT00730535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00730535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring Predictors of Symptoms Relapse After Discontinuation of Successful Treatment With a Tolterodine Prolonged Release Capsules (4 mg, Once Daily) in Overactive Bladder Patients: A Prospective Randomized Multicenter Trial
Lead sponsor
KYU-SUNG LEE
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2006
Completion date
July 31, 2009
Enrollment
173 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder